Position in RPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$135,483,678
+$14,477,147 QoQ
Shares Held
2,416,331
-4.2% QoQ
Ownership
0.420%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#34
of 646 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Derivatives in RPRX
reported options exposure · as of Mar 31, 2026CallValue
$1,199,250
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. RPRX ranks #23 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in RPRX
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $135,483,678 | 2,416,331 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $121,006,531 | 2,522,546 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,199,250 | 25,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $966,000 | 25,000 | Call | Defined | 2026-03-25 | |
| 2025-12-31 | $59,926,774 | 1,550,900 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $58,057,720 | 1,645,627 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $13,902,859 | 385,869 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,050,753 | 419,234 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $14,442,511 | 566,151 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $13,308,151 | 470,419 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,416,827 | 319,182 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $18,312,745 | 602,988 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $80,605,544 | 2,869,546 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $114,264,691 | 4,210,195 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $112,110,500 | 3,647,056 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $82,989,519 | 2,303,345 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $48,272,059 | 1,221,459 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $55,316,005 | 1,376,705 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $41,473,594 | 986,527 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $54,062,064 | 1,387,630 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $3,896,000 | 100,000 | Call | Defined | 2022-05-16 | |
| 2021-12-31 | $52,024,971 | 1,305,520 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $32,432,143 | 897,403 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $2,787,320 | 68,000 | Call | Defined | 2021-08-13 | |
| 2021-06-30 | $39,518,499 | 964,101 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $17,106,455 | 392,170 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $26,414,388 | 527,760 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,400,239 | 175,903 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,476,065 | 30,403 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||